Tienda Elsevier
Regístrese
metricas

Annals of Hepatology

Suggestions
Find all results
Annals of Hepatology
Annals of Hepatology
ISSN: 1665-2681

Annals of Hepatology (AoH) is an international, open access journal published bi-monthly with funds from the Fundación Clínica Médica Sur. It is the official journal of the Mexican Association of Hepatology (AMH), the Latin American Association for the Study of the Liver (ALEH), the Canadian Association for the Study of the Liver (CASL) and the Czech Society of Hepatology (CSH). AoH publishes editorials, opinions, concise reviews, original articles, brief reports, letters to the editor, news from affiliated associations, clinical practice guidelines and summaries of congresses in the field of Hepatology.

Topics covered by AoH include alcoholic liver disease, autoimmune hepatitis, biliary diseases, drug-induced liver injury, genetic liver diseases, NAFLD/NASH and viral hepatitis (HAV, HBV, HCV, HDV, HEV). Our journal seeks to publish articles on basic clinical care and translational research focused on preventing rather than treating the complications of end-stage liver disease.

See more Open Access Option
Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), Science Citation Index Expanded (SCIE), SCImago Journal Rank (SJR), SNIP

See more
Follow us:
RSS
Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

See more
Impact factor 2024
4.4
Citescore

CiteScore measures average citations received per document published.

See more
Citescore 2024
9.1
SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more
SJR 2024
1.011
SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

See more
SNIP 2024
1.057
Time to first decision

The median number of days it takes for an article to go from submission to first editorial decision.

See more
Time to first decision
8 days
View more metrics
Hide
Last published articles
Original article
Telemedicine and hybrid engagement models facilitate hepatitis C cascade of care during periods of healthcare disruption
Sabrina Fan, Haris Imsirovic, Curtis Cooper
Ann Hepatol. 2026;31:102178
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Original article
A three-gene resistome signature as a prognostic tool in hepatocellular carcinoma
Anabel Sanchez-Martin, Rocio I.R. Macias, Luis Muñoz-Bellvís, Luis M. Gonzalez, Alejandro Forner, Maria Reig, Jose J.G. Marin, Oscar Briz
Ann Hepatol. 2026;31:102179
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Original article
Outcomes and risk of relapse after living donor and deceased donor liver transplantation for alcohol-associated liver disease
Chloe Huen Wai Choy, Hills King Hei Suen, Tiffany Cho Lam Wong, Miu Yee Chan, Kin Pan Au, Jeff Wing Chiu Dai, James Yan Yue Fung, Tan To Cheung, Albert Chi Yan Chan
Ann Hepatol. 2026;31:102177
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Original article
Serum bilirubin concentrations and their association with clinical and radiological outcomes in multiple sclerosis: A large cohort study
Tomáš Uher, Pavlína Kleinová, Jana Woronyczová, Lubomír Štěpánek, Manuela Vaněčková, Jan Krásenský, Renata Cífková, Dana Horáková, ... Libor Vítek
Ann Hepatol. 2026;31:102117
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Latest issue
Issue
Cover Vol. 31. Issue 1. (In progress)Vol. 31. Issue 1. (In progress)
(January - June 2026)
This issue is in progress but contains articles that are final and fully citable.
Opinions
Beyond the association: towards an integrated hepato–renal approach
Juanita Pérez-Escobar, Ricardo Ivan Velazquez-Silva, Paulina Carpinteyro-Espin, José Carlos Gasca-Aldama
Ann Hepatol. 2026;31:102155
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Original Articles
Impact of neohepatic albumin-bilirubin scores on renal outcomes following living donor liver transplantation: a propensity score analysis
Hye-Won Jeong, Hye-Mee Kwon, Sung-Hoon Kim, Seong-Mi Yang, In-Gu Jun, Jun-Gol Song, Gyu-Sam Hwang
Ann Hepatol. 2026;31:102111
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Prognosis of hepatocellular carcinoma in the French overseas territories and comparison with a tertiary center in mainland France
Alolia Aboikoni, Manon Allaire, Dominique Louvel, Marthe Alogo A. Nwatsok, Paul Ngock Dime, Ala Ouni, Larissa Tangan, Magaly Zappa, ... Moana Gelu-Simeon
Ann Hepatol. 2026;31:102120
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
Diagnosis of metabolic dysfunction-associated steatotic liver disease by triglyceride glucose-body mass index: A systematic review and meta-analysis
Kexin Du, Yafang Huang, Yanhui Yu, Jianrong Guo, Jianmei Feng, Feng Jiang
Ann Hepatol. 2026;31:102122
Full text access
Share
Bluesky
Linkedin
whatsapp
Email
View latest issue View all issues
Ahead of print

Ahead of print are accepted, peer reviewed articles that are not yet assigned to volumes/issues, but are citable using DOI. More info

Reply to: Comment on “Pancreatic involvement and its prognostic impact in acute-on chronic liver failure”
Georg Kramer, Thomas Reiberger
Full text access
Pre-proof. Available online 9 February 2026
Share
Bluesky
Linkedin
whatsapp
Email
Adult-to-adult living donor liver transplantation in a low-middle income country setting: eight-year experience from Colombia’s first program
Gilberto Mejía, Nathaly Ramírez, Carlos Benavides, Jairo Rivera, María Camila Álvarez, Ana María Martínez, Juan Manuel Pérez, Isabel Quiroga, ... Luis Manuel Barrera
Full text access
Uncorrected Proof. Available online 6 February 2026
Share
Bluesky
Linkedin
whatsapp
Email
ALEH position statement on the management of hepatitis B virus infection 2025
Mario Guimarães Pessoa, Nelia Hernandez, Graciela Castro Narro, Angelo A. Mattos, Marcelo Silva, Alejandro Soza, Lucy Dagher, Martin Padilla-Machaca, ... Latin American Association for the Study of the Liver (ALEH).
Full text access
Pre-proof. Available online 2 February 2026
Share
Bluesky
Linkedin
whatsapp
Email
View all Ahead of print
Editorial Board
Norberto C. Chávez-Tapia
Norberto C. Chávez-Tapia, MD, PhD
Fundación Clínica Médica Sur, Mexico City, Mexico
View editorial board
All issues
portada-Vol. 31. Issue 1. (In progress)
January - June
Volume 31 . Issue. 1
In progress
portada-Vol. 30. Issue 2.
July - December
Volume 30 . Issue. 2
portada-Vol. 30. Issue 1.
January - June
Volume 30 . Issue. 1
portada-Vol. 29. Issue 6.
November - December
Volume 29 . Issue. 6
View all issues
Supplements
portada-Vol. 30. Issue S2.
September
Volume 30. Issue. S2
Abstracts of the 2025 Annual Meeting of the ALEH
portada-Vol. 30. Issue S1.
April
Volume 30. Issue. S1
Abstracts Asociación Mexicana de Hepatología (AMH) 2024
portada-Vol. 29. Issue S3.
December
Volume 29. Issue. S3
Abstracts of the 2024 Annual Meeting of the ALEH
portada-Vol. 29. Issue S2.
February
Volume 29. Issue. S2
Abstracts Asociación Mexicana del Hígado (AMH) 2023
View all supplements
Instructions for authors
Publish in Annals of Hepatology
Most often read
Position Paper
Updated recommendations for the management of metabolic dysfunction–associated steatotic liver disease (MASLD) by the Latin American working group
Luis Antonio Diaz, Juan Pablo Arab, Francisco Idalsoaga, Javiera Perelli, Javier Vega, Melisa Dirchwolf, Javiera Carreño, Bárbara Samith, Cynthia Valério, Rodrigo Oliveira Moreira, Mónica Acevedo, Javier Brahm, Nelia Hernández, Adrian Gadano, Claudia P. Oliveira, Marco Arrese, Graciela Castro-Narro, Mario G. Pessoa
10.1016/j.aohep.2025.101903
Ann Hepatol. 2025;30:
This article has been read 39.793 times
View all Most Often read articles

Subscribe to our newsletter

Publish in
Annals of Hepatology
Affiliated societies

 

Article options
Tools